[Clinical and economical effectiveness of the treatment of focal epilepsies].
One hundred and seventy-three patients with symptomatic and probable symptomatic epilepsies, mean age 31.2 years, were studied. The study included evaluation of anamnesis, clinical and neurological examination, routine EEG and/or video-EEG-monitoring, X-ray CT and/or MRI of the brain. The antiepileptic therapy was corrected. The duration of follow-up study was 2 years. General neurologist therapy (initial therapy) and epileptologist therapy (final therapy) were compared using cost-effectiveness analysis, frequency of using different drugs, ABC- and VEN-analysis. The final therapy was effective in 93.1% of cases, a remission was achieved in 53.2%. The ineffective therapy decreased from 56.6 to 6.9%. The ineffective expenses for the initial therapy were 82.8%. The final therapy was significantly effective (p = 0.001) and expensive (p = 0.004) but the cost difference was low (3420 roubles/year).
S V
SV
Kotov
Iu A
IuA
Belova
I G
IG
Rudakova
A S
AS
Kotov
D000328:Adult; D000927:Anticonvulsants / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D004569:Electroencephalography / Q000191:economics*; D004828:Epilepsies, Partial / Q000175:diagnosis / Q000191:economics / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D017048:Health Care Costs / Q000639:trends*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000191:economics*; D008297:Male; D012426:Russia; D014057:Tomography, X-Ray Computed / Q000191:economics*
D000927:Anticonvulsants